vs
爱齐科技（ALGN）与NATIONAL HEALTHCARE CORP（NHC）财务数据对比。点击上方公司名可切换其他公司
爱齐科技的季度营收约是NATIONAL HEALTHCARE CORP的2.7倍（$1.0B vs $386.5M）。爱齐科技净利率更高（13.0% vs 6.4%，领先6.5%）。爱齐科技同比增速更快（5.3% vs 4.6%）。爱齐科技自由现金流更多（$187.3M vs $6.4M）。过去两年NATIONAL HEALTHCARE CORP的营收复合增速更高（14.0% vs 2.5%）
爱齐科技是一家全球知名医疗设备企业，主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务，客户覆盖正畸医师、全科牙医，面向修复、美容牙科领域，业务分为透明矫治器、扫描仪及服务两大板块，可满足青少年等不同群体的正畸需求
HCA Healthcare是1968年成立的美国营利性医疗服务运营商，总部位于田纳西州纳什维尔。截至2020年5月，该公司在全美20个州及英国持有并运营186家医院，还有约2400个医疗服务网点，涵盖手术中心、独立急诊室、紧急护理中心及医师诊所，2024年位列美国财富500强第61位。
ALGN vs NHC — 直观对比
营收规模更大
ALGN
是对方的2.7倍
$386.5M
营收增速更快
ALGN
高出0.6%
4.6%
净利率更高
ALGN
高出6.5%
6.4%
自由现金流更多
ALGN
多$180.9M
$6.4M
两年增速更快
NHC
近两年复合增速
2.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $386.5M |
| 净利润 | $135.8M | $24.8M |
| 毛利率 | 65.3% | — |
| 营业利润率 | 14.8% | 8.6% |
| 净利率 | 13.0% | 6.4% |
| 营收同比 | 5.3% | 4.6% |
| 净利润同比 | 30.8% | 308.6% |
| 每股收益（稀释后） | $1.88 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGNNHC
| Q4 25 | $1.0B | $386.5M | ||
| Q3 25 | $995.7M | $382.7M | ||
| Q2 25 | $1.0B | $374.9M | ||
| Q1 25 | $979.3M | $373.7M | ||
| Q4 24 | $995.2M | $369.4M | ||
| Q3 24 | $977.9M | $340.2M | ||
| Q2 24 | $1.0B | $300.7M | ||
| Q1 24 | $997.4M | $297.2M |
净利润ALGNNHC
| Q4 25 | $135.8M | $24.8M | ||
| Q3 25 | $56.8M | $39.2M | ||
| Q2 25 | $124.6M | $23.7M | ||
| Q1 25 | $93.2M | $32.2M | ||
| Q4 24 | $103.8M | $6.1M | ||
| Q3 24 | $116.0M | $42.8M | ||
| Q2 24 | $96.6M | $26.8M | ||
| Q1 24 | $105.0M | $26.2M |
毛利率ALGNNHC
| Q4 25 | 65.3% | — | ||
| Q3 25 | 64.2% | — | ||
| Q2 25 | 69.9% | — | ||
| Q1 25 | 69.5% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 69.7% | — | ||
| Q2 24 | 70.3% | — | ||
| Q1 24 | 70.0% | — |
营业利润率ALGNNHC
| Q4 25 | 14.8% | 8.6% | ||
| Q3 25 | 9.7% | 7.9% | ||
| Q2 25 | 16.1% | 9.1% | ||
| Q1 25 | 13.4% | 8.2% | ||
| Q4 24 | 14.5% | 7.8% | ||
| Q3 24 | 16.6% | 6.7% | ||
| Q2 24 | 14.3% | 7.5% | ||
| Q1 24 | 15.5% | 5.3% |
净利率ALGNNHC
| Q4 25 | 13.0% | 6.4% | ||
| Q3 25 | 5.7% | 10.3% | ||
| Q2 25 | 12.3% | 6.3% | ||
| Q1 25 | 9.5% | 8.6% | ||
| Q4 24 | 10.4% | 1.6% | ||
| Q3 24 | 11.9% | 12.6% | ||
| Q2 24 | 9.4% | 8.9% | ||
| Q1 24 | 10.5% | 8.8% |
每股收益（稀释后）ALGNNHC
| Q4 25 | $1.88 | $1.58 | ||
| Q3 25 | $0.78 | $2.50 | ||
| Q2 25 | $1.72 | $1.52 | ||
| Q1 25 | $1.27 | $2.07 | ||
| Q4 24 | $1.40 | $0.38 | ||
| Q3 24 | $1.55 | $2.73 | ||
| Q2 24 | $1.28 | $1.73 | ||
| Q1 24 | $1.39 | $1.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $92.8M |
| 总债务越低越好 | — | $40.0M |
| 股东权益账面价值 | $4.0B | $1.1B |
| 总资产 | $6.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.04× |
8季度趋势，按日历期对齐
现金及短期投资ALGNNHC
| Q4 25 | $1.1B | $92.8M | ||
| Q3 25 | $1.0B | $130.6M | ||
| Q2 25 | $901.2M | $111.0M | ||
| Q1 25 | $873.0M | $90.4M | ||
| Q4 24 | $1.0B | $76.1M | ||
| Q3 24 | $1.0B | $84.8M | ||
| Q2 24 | $761.4M | $136.2M | ||
| Q1 24 | $865.8M | $94.0M |
总债务ALGNNHC
| Q4 25 | — | $40.0M | ||
| Q3 25 | — | $73.1M | ||
| Q2 25 | — | $110.0M | ||
| Q1 25 | — | $134.0M | ||
| Q4 24 | — | $137.0M | ||
| Q3 24 | — | $147.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALGNNHC
| Q4 25 | $4.0B | $1.1B | ||
| Q3 25 | $4.0B | $1.1B | ||
| Q2 25 | $3.9B | $1.0B | ||
| Q1 25 | $3.8B | $1.0B | ||
| Q4 24 | $3.9B | $980.2M | ||
| Q3 24 | $3.9B | $983.5M | ||
| Q2 24 | $3.8B | $945.8M | ||
| Q1 24 | $3.8B | $924.7M |
总资产ALGNNHC
| Q4 25 | $6.2B | $1.5B | ||
| Q3 25 | $6.2B | $1.6B | ||
| Q2 25 | $6.2B | $1.6B | ||
| Q1 25 | $6.1B | $1.5B | ||
| Q4 24 | $6.2B | $1.5B | ||
| Q3 24 | $6.4B | $1.6B | ||
| Q2 24 | $6.2B | $1.3B | ||
| Q1 24 | $6.2B | $1.3B |
负债/权益比ALGNNHC
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $223.2M | $16.8M |
| 自由现金流经营现金流 - 资本支出 | $187.3M | $6.4M |
| 自由现金流率自由现金流/营收 | 17.9% | 1.7% |
| 资本支出强度资本支出/营收 | 3.4% | 2.7% |
| 现金转化率经营现金流/净利润 | 1.64× | 0.68× |
| 过去12个月自由现金流最近4个季度 | $490.8M | $148.6M |
8季度趋势，按日历期对齐
经营现金流ALGNNHC
| Q4 25 | $223.2M | $16.8M | ||
| Q3 25 | $188.7M | $66.2M | ||
| Q2 25 | $128.7M | $62.8M | ||
| Q1 25 | $52.7M | $39.3M | ||
| Q4 24 | $286.1M | $12.8M | ||
| Q3 24 | $263.7M | $34.2M | ||
| Q2 24 | $159.8M | $50.7M | ||
| Q1 24 | $28.7M | $9.6M |
自由现金流ALGNNHC
| Q4 25 | $187.3M | $6.4M | ||
| Q3 25 | $169.0M | $56.5M | ||
| Q2 25 | $107.2M | $52.6M | ||
| Q1 25 | $27.4M | $33.1M | ||
| Q4 24 | $263.1M | $4.6M | ||
| Q3 24 | $233.9M | $28.6M | ||
| Q2 24 | $106.4M | $42.8M | ||
| Q1 24 | $19.3M | $3.7M |
自由现金流率ALGNNHC
| Q4 25 | 17.9% | 1.7% | ||
| Q3 25 | 17.0% | 14.8% | ||
| Q2 25 | 10.6% | 14.0% | ||
| Q1 25 | 2.8% | 8.9% | ||
| Q4 24 | 26.4% | 1.3% | ||
| Q3 24 | 23.9% | 8.4% | ||
| Q2 24 | 10.3% | 14.2% | ||
| Q1 24 | 1.9% | 1.2% |
资本支出强度ALGNNHC
| Q4 25 | 3.4% | 2.7% | ||
| Q3 25 | 2.0% | 2.5% | ||
| Q2 25 | 2.1% | 2.7% | ||
| Q1 25 | 2.6% | 1.6% | ||
| Q4 24 | 2.3% | 2.2% | ||
| Q3 24 | 3.0% | 1.7% | ||
| Q2 24 | 5.2% | 2.6% | ||
| Q1 24 | 0.9% | 2.0% |
现金转化率ALGNNHC
| Q4 25 | 1.64× | 0.68× | ||
| Q3 25 | 3.33× | 1.69× | ||
| Q2 25 | 1.03× | 2.65× | ||
| Q1 25 | 0.57× | 1.22× | ||
| Q4 24 | 2.76× | 2.10× | ||
| Q3 24 | 2.27× | 0.80× | ||
| Q2 24 | 1.66× | 1.89× | ||
| Q1 24 | 0.27× | 0.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALGN
暂无分部数据
NHC
| Inpatient Services Segment | $333.7M | 86% |
| Homecare Services Segment | $40.0M | 10% |
| Other | $11.2M | 3% |
| National | $1.6M | 0% |
